Availability of highly sensitive troponin assays and acute coronary syndrome care: Insights from the SNAPSHOT registry

Medical Journal of Australia

Volumn 202, Issue 1, 2015, Pages 36-40

  Cullen, Louise ^a   French, John K ^b,c   Briffa, Tom G ^c   Redfern, Julie ^d   Hammett, Christopher J K ^a   Brieger, David B ^e   Parsonage, William A ^a   Lefkovits, Jeffrey ^f   Ellis, Chris ^g   Astley, Carolyn ^h,i   Eleanor Howell, Tegwen ^d   Elliott, John M ^j   Chew, Derek P B ^k  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h SA Health   (Australia)

ⁱ FLINDERS UNIVERSITY   (Australia)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k FLINDERS MEDICAL CENTRE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TROPONIN T; BIOLOGICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ARTICLE; ASSAY; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HIGHLY SENSITIVE TROPONIN ASSAY; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; UNSTABLE ANGINA PECTORIS; AUSTRALIA; BLOOD; NEW ZEALAND; PROSPECTIVE STUDY; REGISTER; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AUSTRALIA; BIOLOGICAL MARKERS; NEW ZEALAND; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME; TROPONIN;

EID: 84921779390     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00275     Document Type: Article

References (8)

1. The economic costs of heart attack and chest pain (acute coronary syndrome). Canberra: Access Economics, 2009. http://www.bakeridi.edu.au/Assets/Files/FullReport%20-%20the%20economic%20costs%20of%20heart%20attack%20and%20chest%20pain%20%28emilable.pdf (accessed Dec 2014).
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation2012; 126: 2020-2035.
3. Reichlin T, Twerenbold R, Reiter M, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012; 125: 1205-1213.
4. Chew DP, Aroney CN, Aylward PE, et al. Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ2011; 20: 487-502.
5. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem2012; 58: 54-61.
6. Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem2009; 55: 1303-1306.
7. Chew DP, French J, Briffa TG, et al. Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. Med J Aust2013; 199: 185-191.
8. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem2012; 58: 1574-1581.